Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mearns

Showing results (401-410 of 483) with videos related to

Pageof 49
Sort By:
Plos One|January 4, 2013
Nippostrongylus-induced intestinal hypercontractility requires IL-4 receptor alpha-responsiveness by T cells in miceSaskia Schmidt, J Claire Hoving, William G C Horsnell, et al.
Melanoma Management|September 8, 2018
Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic reviewElizabeth S Mearns, Jill A Bell, Aaron Galaznik, et al.
Journal of Biomolecular Screening|September 18, 2012
Development of a high-throughput cell-based assay for identification of IL-17 inhibitorsSvetlana V Dobritsa, Iok Teng Kuok, Hai Nguyen, et al.
Ecology|March 7, 2018
Dispersal: a matter of scaleElise R Morton, Michael J McGrady, Ian Newton, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1995
Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecinV I Khaoustov, A Ozer, J R Smith, et al.
Marine Drugs|August 26, 2021
Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced ChondrogenicityZara Ahmed, Lydia C Powell, Navid Matin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2025
A Generalized Risk Adjusted Cost Effectiveness (GRACE) Economic Model for Measuring the Value of Interventions that Delay Mobility Impairment Across Neurological ConditionsJason Shafrin, Jaehong Kim, Jacob Fajnor, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 2, 2017
Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the USElizabeth S Mearns, Michael Liang, Brendan L Limone, et al.
Forum for Health Economics & Policy|July 15, 2025
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in NeurologyJason Shafrin, Kyi-Sin Than, Jacob Fajnor, et al.
The British Journal of Surgery|February 1, 1990
Efficacy of continuous extrapleural intercostal nerve block on post-thoracotomy pain and pulmonary mechanicsS Sabanathan, A J Mearns, P J Bickford Smith, et al.
Pageof 49

Showing results (401-410 of 483) with videos related to

Sort By:
Pageof 49
Plos One|January 4, 2013
Nippostrongylus-induced intestinal hypercontractility requires IL-4 receptor alpha-responsiveness by T cells in miceSaskia Schmidt, J Claire Hoving, William G C Horsnell, et al.
Melanoma Management|September 8, 2018
Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic reviewElizabeth S Mearns, Jill A Bell, Aaron Galaznik, et al.
Journal of Biomolecular Screening|September 18, 2012
Development of a high-throughput cell-based assay for identification of IL-17 inhibitorsSvetlana V Dobritsa, Iok Teng Kuok, Hai Nguyen, et al.
Ecology|March 7, 2018
Dispersal: a matter of scaleElise R Morton, Michael J McGrady, Ian Newton, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1995
Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecinV I Khaoustov, A Ozer, J R Smith, et al.
Marine Drugs|August 26, 2021
Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced ChondrogenicityZara Ahmed, Lydia C Powell, Navid Matin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2025
A Generalized Risk Adjusted Cost Effectiveness (GRACE) Economic Model for Measuring the Value of Interventions that Delay Mobility Impairment Across Neurological ConditionsJason Shafrin, Jaehong Kim, Jacob Fajnor, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 2, 2017
Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the USElizabeth S Mearns, Michael Liang, Brendan L Limone, et al.
Forum for Health Economics & Policy|July 15, 2025
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in NeurologyJason Shafrin, Kyi-Sin Than, Jacob Fajnor, et al.
The British Journal of Surgery|February 1, 1990
Efficacy of continuous extrapleural intercostal nerve block on post-thoracotomy pain and pulmonary mechanicsS Sabanathan, A J Mearns, P J Bickford Smith, et al.
Pageof 49